CA
NZ
UK
AU
IND
US
Trulieve Cannabis (NYSE:TRLV) shares are trading sharply higher today after the company confirmed it has been added to the S&P TotalMarket Indexand S&P Completion Index, along with related health care sector sub-indices.
Management has been upfront that these sessions are not expected to include new clinical data, regulatory updates, or financing announcements. Instead, the company has characterized the discussions as covering routine business operations — the kind of corporate-update format that gives existing and prospective investors …
Start with Viking Therapeutics, because the obesity space still pulls the most attention, and for good reason. The company's VK2735 data answered a question that's been nagging at the entire GLP-1 category: what happens when you stretch out the dosing? Patients who moved from …
NAVREF, the National Association of Veterans' Research and Education Foundations, is a natural venue for this kind of data given the company's clear strategic emphasis on the veteran and military health system as a distribution channel. Veterans face elevated rates of lung cancer risk …
That kind of multi-year runway is a meaningfulCompetitive Advantagein biotech, where clinical-stage companies frequently face the risk of needing to raiseCapitalat inopportune moments, often diluting existing shareholders at depressed valuations if a data readout disappoints or market conditions sour. Having runway that stretches more …
Paxalisib was originally developed and studied as an oncology candidate, most notably in difficult-to-treat brain cancers. Moving the same molecule into rare seizure disorders is a strategy familiar to biotech investors: repurposing a drug with an established safety profile into a new indication can …
HLP003 is described as a modified psilocin derivative. Psilocin is the active compound the body produces after metabolizing psilocybin, the substance found in so-called 'magic mushrooms' that has drawn growing clinical interest for mental health applications in recent years. By working with a modified …
The numbers behind that headline are notable. Patients on tegoprubart posted a mean estimated glomerular filtration rate, or eGFR, of 71 mL/min/1.73 m², compared to 58 for those on tacrolimus. eGFR is the standard clinical measure of how well the kidneys are filtering blood, …
That dual coverage is the real story here. Most antiviral candidates are built and tested against a single target. Showing effectiveness across two distinct viruses in the same family is the kind of early signal that supports a much broader ambition: a pan-filovirus prophylactic …
Chronic spontaneous urticaria is a condition marked by recurring hives and swelling with no identifiable external trigger, and it can persist for months or years, significantly affecting patients' quality of life. Current treatment options, including the widely used antibody therapy omalizumab, don't work for …
Please wait processing your request...